Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM1315MO2
TNBC
Basal B
Nilotinib
ABL
nRTK
12428.17
uM
inf
inf
1.0500 1.0500 0.0000 -0.0450
-2.6385
0.9724
MB 157
Unknown
Unknown
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7482.084
uM
inf
inf
1.0106 1.0106 0.0000 -0.0449
-13.5536
1.8697
Hs 578T
TNBC
Basal B
PS-1145
IKK
NFKB
7475.065
uM
inf
inf
1.0453 1.0453 0.0000 -0.0447
-24.5864
2.6262
SUM185PE
TNBC
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7532.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0445
-2.0993
0.7413
MDA-MB-231
TNBC
Basal B
PS-1145
IKK
NFKB
7504.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0441
-20.3886
1.6220
HCC1569
HER2amp
Basal A
Cetuximab
EGFR
ErbB
9347.026
uM
inf
inf
1.0500 1.0500 0.0000 -0.0441
-22.3629
1.2965
UACC-812
HER2amp
Luminal
Cetuximab
EGFR
ErbB
10267.026
uM
inf
inf
1.0500 1.0500 0.0000 -0.0438
-8.1346
0.3125
Hs 578T
TNBC
Basal B
AG1024
IGF1R
RTK
7473.066
uM
inf
inf
1.0500 1.0500 0.0000 -0.0434
-6.5378
2.3582
MDA-MB-361
HER2amp
Luminal
Sulindac sulfide
COX1/2
COX
10643.136
uM
inf
inf
1.0500 1.0500 0.0000 -0.0432
-6.6439
0.5141
SUM1315MO2
TNBC
Basal B
Nilotinib
ABL
nRTK
10875.145
uM
inf
inf
1.0500 1.0500 0.0000 -0.0427
-3.3446
0.7643
CAMA-1
HR+
Luminal
Trastuzumab
HER2
ErbB
9210.026
uM
inf
inf
0.9536 0.9536 0.0000 -0.0426
-1.3374
0.9102
ZR-75-1
HR+
Luminal
Cetuximab
EGFR
ErbB
7932.052
uM
inf
inf
1.0500 1.0500 0.0000 -0.0419
-4.4238
0.8877
MDA-MB-415
HR+
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7510.094
uM
inf
inf
1.0500 1.0500 0.0000 -0.0419
-8.1247
0.8152
BT-549
TNBC
Basal B
AG1024
IGF1R
RTK
5910.066
uM
inf
inf
1.0203 1.0203 0.0000 -0.0416
-10.1657
3.0773
Hs 578T
TNBC
Basal B
Methotrexate
DHFR
Metabolism
7475.084
uM
inf
inf
1.0500 1.0500 0.0000 -0.0415
-7.3003
2.7804
CAMA-1
HR+
Luminal
Ribavirin
15348.211
uM
inf
inf
1.0500 1.0500 0.0000 -0.0410
-5.7835
0.7490
Hs 578T
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7473.091
uM
inf
inf
0.9017 0.9017 0.0000 -0.0408
-0.0238
2.3297
Hs 578T
TNBC
Basal B
Purvalanol A
CDK1
CDK
7475.067
uM
inf
inf
1.0500 1.0500 0.0000 -0.0408
-9.2547
2.4078
HCC1428
HR+
Luminal
PS-1145
IKK
NFKB
7442.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0407
-6.6988
0.7805
MX1
Unknown
Unknown
PS-1145
IKK
NFKB
7523.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0407
-9.0127
0.7668
MCF 10F
NM
-
Cetuximab
EGFR
ErbB
7871.018
uM
inf
inf
0.9011 0.9011 0.0000 -0.0407
-0.0154
1.1973
LY2
HR+
Luminal
Erlotinib
EGFR
ErbB
10380.092
uM
inf
inf
0.9525 0.9525 0.0000 -0.0404
-1.1056
1.4888
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
9146.122
uM
inf
inf
0.9694 0.9694 0.0000 -0.0404
-1.9847
1.3408
HCC1569
HER2amp
Basal A
PD 98059
MEK
MAPK
12523.152
uM
inf
inf
1.0310 1.0310 0.0000 -0.0401
-9.8795
0.8423
HCC38
TNBC
Basal B
Trametinib
MEK
MAPK
9028.05
uM
inf
inf
1.0500 1.0500 0.0000 -0.0399
-2.6337
0.9299